tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LYEL Stock Latest News

Lyell Immunopharma: Differentiated CAR-T Durability and Second-Line LBCL Opportunity Underpin Buy Rating and $45 Target
RatingsLyell Immunopharma: Differentiated CAR-T Durability and Second-Line LBCL Opportunity Underpin Buy Rating and $45 Target
7d ago
LYEL
Lyell Immunopharma initiates patient dosing in PiNACLE-H2H Phase 3 trial
PremiumThe Fly
Lyell Immunopharma initiates patient dosing in PiNACLE-H2H Phase 3 trial
8d ago
LYEL
Lyell Immunopharma trading resumes
PremiumThe Fly
Lyell Immunopharma trading resumes
2M ago
LYEL
Lyell Immunopharma trading halted, volatility trading pause
PremiumThe Fly
Lyell Immunopharma trading halted, volatility trading pause
2M ago
LYEL
Lyell Immunopharma upgraded to Buy from Neutral at H.C. Wainwright
PremiumThe Fly
Lyell Immunopharma upgraded to Buy from Neutral at H.C. Wainwright
2M ago
LYEL
Lyell Immunopharma Presents Promising CAR T-Cell Data
PremiumCompany AnnouncementsLyell Immunopharma Presents Promising CAR T-Cell Data
2M ago
8K
LYEL
Lyell Immunopharma announces new data from trial of rondecabtagene autoleucel
Premium
The Fly
Lyell Immunopharma announces new data from trial of rondecabtagene autoleucel
2M ago
LYEL
Lyell Immunopharma files to sell 1.9M shares of common stock for holders
Premium
The Fly
Lyell Immunopharma files to sell 1.9M shares of common stock for holders
3M ago
LYEL
Lyell Immunopharma Modernizes Bylaws for Shareholder Engagement
PremiumCompany Announcements
Lyell Immunopharma Modernizes Bylaws for Shareholder Engagement
3M ago
8K
LYEL
Lyell Immunopharma price target raised to $20 from $10 at H.C. Wainwright
PremiumThe Fly
Lyell Immunopharma price target raised to $20 from $10 at H.C. Wainwright
3M ago
LYEL
Lyell Immunopharma Reports Q3 2025 Financial Results
PremiumCompany Announcements
Lyell Immunopharma Reports Q3 2025 Financial Results
3M ago
LYEL
Lyell Immunopharma reports Q3 revenue $15k vs $34k last year
PremiumThe Fly
Lyell Immunopharma reports Q3 revenue $15k vs $34k last year
3M ago
LYEL
Lyell Immunopharma acquires exclusive global rights to LYL273
PremiumThe FlyLyell Immunopharma acquires exclusive global rights to LYL273
3M ago
LYEL
Lyell Immunopharma Secures Global Rights for LYL273
Premium
Company Announcements
Lyell Immunopharma Secures Global Rights for LYL273
3M ago
8K
LYEL
LYEL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
LYEL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
LYEL
Lyell Immunopharma Appoints New Financial Leadership Team
PremiumCompany Announcements
Lyell Immunopharma Appoints New Financial Leadership Team
4M ago
8K
LYEL
Lyell Immunopharma’s LYL314 Study: A Promising Step in Lymphoma Treatment
PremiumCompany Announcements
Lyell Immunopharma’s LYL314 Study: A Promising Step in Lymphoma Treatment
4M ago
LYEL
Lyell Immunopharma’s New CAR T-Cell Therapy Trial: A Potential Game-Changer in Lymphoma Treatment?
PremiumCompany Announcements
Lyell Immunopharma’s New CAR T-Cell Therapy Trial: A Potential Game-Changer in Lymphoma Treatment?
4M ago
LYEL
Lyell Immunopharma initiated with a Buy at Lucid Capital
PremiumThe Fly
Lyell Immunopharma initiated with a Buy at Lucid Capital
5M ago
LYEL
Lyell Immunopharma CFO Resignation Announced
PremiumCompany AnnouncementsLyell Immunopharma CFO Resignation Announced
5M ago
8K
LYEL
Lyell announces initiation of Phase 3 head-to-head CAR T-cell therapy trial
Premium
The Fly
Lyell announces initiation of Phase 3 head-to-head CAR T-cell therapy trial
6M ago
LYEL
Lyell Immunopharma Advances CAR T-Cell Therapies
Premium
Company Announcements
Lyell Immunopharma Advances CAR T-Cell Therapies
6M ago
LYEL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >